The iShares Core MSCI EAFE is a low-cost exchange-traded fund that invests in many top international stocks.Investing in U.S. stocks has been a time-tested way to grow your wealth over the years. That's evident with the performance of the S&P 500 index, which includes the top companies on the U.S. markets: It has risen by close to 80% in just the past three years.But because the index has risen so much in a relatively short time frame, you may want to consider investments in other parts of the world that ca ...

Financial Data and Key Metrics Changes - CACI reported revenue of $2.2 billion for Q2 2026, reflecting a year-over-year growth of 5.7%, with organic growth of 4.5% [15] - EBITDA margin increased by 70 basis points year-over-year to 11.8% [15] - Adjusted diluted earnings per share rose by 14% to $6.81 compared to the previous year [15] - Free cash flow for the quarter was $138 million, driven by strong profitability and effective working capital management [15] Business Line Data and Key Metrics Changes - The technology segment has grown to represent nearly 60% of total revenue, with significant contributions from electronic warfare and agile software development [5][7] - Electronic warfare alone generated approximately $2 billion in revenue [7] - The company won $1.4 billion in awards during the quarter, resulting in a book-to-bill ratio of 0.65 for the quarter and 1.3 on a trailing 12-month basis [6][19] Market Data and Key Metrics Changes - 90% of CACI's revenue comes from national security customers, with a backlog of $33 billion, which increased by 3% year-over-year [12][19] - Funded backlog grew by 7% over the same period [19] - The company expects 95% of its revenue for FY 2026 to come from existing programs, with 3% from recompetes and 2% from new business [19] Company Strategy and Development Direction - CACI's strategy focuses on expanding national security capabilities and investing in technology to meet customer needs [4][5] - The company aims to differentiate itself through software-defined technology and agile development methodologies [11][22] - The recent acquisition of ARCA is part of CACI's strategy to enhance its technology portfolio and position in the space market [13][54] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's ability to navigate a dynamic operating environment and drive long-term shareholder value [6][23] - The company raised its fiscal 2026 guidance, expecting revenue growth of 8%-10% and free cash flow of at least $725 million [12][18] - Management noted that reconciliation funds are beginning to flow, positively impacting border security programs and other areas [42] Other Important Information - CACI's leverage at the end of Q2 was 2.4 times net debt to trailing 12-month EBITDA, expected to rise to 4.3 times post-ARCA acquisition [16][17] - The company has a strong track record of quickly deleveraging after acquisitions [17] Q&A Session Summary Question: What does higher U.S. military op tempo mean for CACI? - Management indicated that the current operational tempo is favorable for CACI, as it aligns with the demand for mission technology that traditional companies may not provide [27][28] Question: How is the pipeline of submitted bids expected to flow? - Management acknowledged that the protracted government shutdown affected the pace of acquisition processes but noted that the pipeline is filling back up [32] Question: Can you provide an update on the recent protest win? - Management confirmed that the JTMS protest was denied, allowing the company to ramp up on the program, which is expected to benefit growth in 2027 and 2028 [40] Question: How does reconciliation funding impact CACI? - Management stated that reconciliation funding is expected to positively impact various programs, including border security and modernization efforts [42] Question: What is the status of the Federal Acquisition Regulation reform? - Management noted that CACI is aligned with the ongoing acquisition reform and is well-positioned to support the government's shift towards more commercial models [48] Question: How does CACI view the competitive landscape with L3Harris? - Management emphasized that CACI continues to see strong demand for its technology and is focused on delivering value, regardless of competitors' actions [66] Question: What is the outlook for defense spending growth in 2027? - Management expressed caution regarding the fiscal year 2027 budget but remains confident in CACI's growth potential within its $300 billion total addressable market [75] Question: What are the drivers behind the strong margins this quarter? - Management attributed the strong margins to favorable technology revenue acceleration and effective management of indirect costs [86]

It seems investors have made up their minds that as the AI revolution unfolds, software companies are doomed. This is why shareholders of companies such as Adobe ( ADBE ), Salesforce ( CRM ), Intuit ( INTUI’m a long-term investor focused on U.S. and European equities, with a dual emphasis on undervalued growth stocks and high-quality dividend growers. Through years of experience, I’ve learned that sustained profitability—evident in strong margins, stable and expanding free cash flow, and high returns on inv ...

Kyndryl and SAP have a long-standing strategic alliance and Kyndryl recently achieved recognition as a global RISE with SAP delivery partner. In addition to leveraging AI within its Clean Field approach, Kyndryl is applying AI-driven services for several SAP solutions to accelerate customers' adoption and optimization of SAP transformation initiatives. Visit the Kyndryl and SAP global alliance page to learn more. Kyndryl's collaboration with Nova Intelligence underpins new Clean Field approach that supports ...

Core Viewpoint - Shares in Germany's SAP have continued a months-long downtrend, reaching their lowest point since August 2024, with a total market value loss of approximately $130 billion since last year's record high [1] Group 1 - SAP's stock price decline has been significant, indicating ongoing challenges for the company [1] - The current market value loss reflects a substantial decrease from previous highs, highlighting investor concerns [1]

It has been a strong year-plus for European equities, but not all names have participated in the big bull run. SAP SE ( SAP ) is down 10% over the past 12 months, badly lagging the Vanguard FTSEFreelance Financial Writer | Investments | Markets | Personal Finance | RetirementI create written content used in various formats including articles, blogs, emails, and social media for financial advisors and investment firms in a cost-efficient way. My passion is putting a narrative to financial data. Working with ...

Group 1 - European equities have experienced a strong performance over the past year, but not all companies have benefited equally, with SAP SE down 10% in the last 12 months [1] - SAP SE's performance has significantly lagged behind the Vanguard FTSE, indicating potential challenges for the company in the current market environment [1]

We came across a bullish thesis on BlackLine, Inc. on r/valueinvesting by Exciting-Context6012. In this article, we will summarize the bulls’ thesis on BL. BlackLine, Inc.'s share was trading at $52.65 as of Janaury 16th. BL’s trailing P/E was 47.86 according to Yahoo Finance. invest, investment, accountant, accounting, account, money, funds, business, trade, market, earnings, capital, risk, wealth, man, growth, index, foreign, profits, return, desk, Nonwarit/Shutterstock.com BlackLine, Inc. (BL) is a p ...

I wouldn't want to be on the wrong side of one of the biggest mega cycles in stock market history, which is why I don't envy SAP ( SAP ) and its software peers.I aim to invest in companies with perfect qualitative attributes, buy them at an attractive price based on fundamentals, and hold them forever. I hope to publish articles covering such companies approximately 3 times per week, with extensive quarterly follow-ups and constant updates.I manage a concentrated portfolio targeted at avoiding losers and ma ...

Group 1 - Novo Nordisk's stock surged by 8% on January 16, reaching a peak of $62.02, the highest level since September of the previous year, with a market capitalization of $273.5 billion [1] - The early prescription data for Novo Nordisk's newly launched oral GLP-1 medication for obesity shows promising results, with approximately 3,100 prescriptions in the first week [3] - Comparatively, Eli Lilly's injectable weight loss drug Zepbound garnered about 1,900 prescriptions in its first full week post-launch, indicating a strong start for Novo Nordisk's oral medication [3] Group 2 - Analysts caution that more data is needed to fully assess the early demand for the Wegovy oral medication [4] - The direct sales channel is expected to have significant potential for promoting the oral medication, and analysts are eager to see its complete performance [5] - The weight loss and diabetes medication market is experiencing rapid growth, with Eli Lilly holding a significant market share and preparing to launch its own oral obesity medication [6] Group 3 - The demand landscape may change in the coming months with the anticipated market entry of Eli Lilly's oral drug orforglipron [7] - Although Novo Nordisk currently has a first-mover advantage, its peptide-based medication has dietary restrictions that may affect user acceptance [7] - In contrast, Eli Lilly's drug is a small molecule compound, which does not have the same dietary limitations [8]